Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Syndax Pharmaceuticals (SNDX) Cash from Operations (2016 - 2026)

Syndax Pharmaceuticals (SNDX) has disclosed Cash from Operations for 12 consecutive years, with 50345000.0 as the latest value for Q1 2026.

  • For Q1 2026, Cash from Operations rose 47.1% year-over-year to 50345000.0; the TTM value through Mar 2026 reached 278163000.0, up 2.92%, while the annual FY2025 figure was 322980000.0, 17.49% down from the prior year.
  • Cash from Operations hit 50345000.0 in Q1 2026 for Syndax Pharmaceuticals, up from 69488000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 22894000.0 in Q4 2022 and bottomed at 95162000.0 in Q1 2025.
  • Average Cash from Operations over 5 years is 55441411.76, with a median of 50345000.0 recorded in 2026.
  • Year-over-year, Cash from Operations plummeted 122.73% in 2022 and then skyrocketed 47.1% in 2026.
  • Syndax Pharmaceuticals' Cash from Operations stood at 22894000.0 in 2022, then plummeted by 80.61% to 41349000.0 in 2023, then crashed by 38.79% to 57388000.0 in 2024, then fell by 21.08% to 69488000.0 in 2025, then rose by 27.55% to 50345000.0 in 2026.
  • According to Business Quant data, Cash from Operations over the past three periods came in at 50345000.0, 69488000.0, and 70535000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.